A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry - Wikidata - awgldk - TriplyDB

A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry

A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry

http://www.wikidata.org/entity/Q34405695

about

Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review Detection of three closely located single nucleotide polymorphisms in the EAAT2 promoter: comparison of single-strand conformational polymorphism (SSCP), pyrosequencing and Sanger sequencing.Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.Automated tumor analysis for molecular profiling in lung cancer.EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial In situ Protein Detection for Companion Diagnostics.EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report.The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.Molecular pathology in lung cancer: a guide to the techniques used in clinical practice.Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.Pragmatic issues in biomarker evaluation for targeted therapies in cancer.CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations.Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression.Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value.Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.Quantum dots immunofluorescence histochemical detection of EGFR gene mutations in the non-small cell lung cancers using mutation-specific antibodies.Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.Immunohistochemistry with a novel mutation-specific monoclonal antibody as a screening tool for the EGFR L858R mutational status in primary lung adenocarcinoma.Detecting EGFR alterations in clinical specimens-pitfalls and necessities.Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS.[Value of immunohistochemical staining with mutation-specific antibodies in detecting EGFR mutations: a meta-analysis].The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer.Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma.

P2860

Q26785713-2D2D87E5-7D71-423A-AD81-573B4F4E623A Q33959301-D3A62EF3-8ADD-4FD9-83A6-6C951567A357 Q35078128-24E3449C-0021-444A-B7D1-9D050A025FCA Q35244225-29D64C67-9A08-40B0-B2CC-810F9916AE58 Q36059989-BF4C6E0C-6D5E-475F-B2E5-0CF1989BEB50 Q36413949-6AAB8F76-C6D7-43F5-AFA0-33070842A98F Q36557678-DF9C45E5-7999-4BA7-9725-43B99B596040 Q36962487-C92A3B77-71EF-49AB-A959-32D8FFBB786C Q37251422-E7E1FC84-7017-4DEA-A1B6-D7ACFAEC3422 Q37270405-88CF2B69-692F-469F-BFA6-22AA50EDF694 Q37345446-4E962136-50E5-4791-97C0-49C1492A0A01 Q37345952-885E2A29-43A1-4423-8D99-222D15713E62 Q38240593-988EBFF4-4A31-400F-A080-92552195119A Q38263419-305365ED-3546-4718-81F5-66DB77F4B9DA Q38271031-6B017683-8246-4F49-8F07-AE3AB0638AB4 Q38924458-6476C0D7-815F-46A1-8FEA-5F0E02C58D18 Q39002233-DA1A77F5-83D8-48A8-92B7-DA59EEB55FF5 Q39476678-8A3FCB47-DEEE-46D2-ABB2-0A278A54405D Q40393934-779F5D0F-7ED6-48DC-B387-C9461DA74B3E Q40502030-229F9B32-0E78-4A7F-A508-FAB6A8D87536 Q42633890-845239DA-A421-4B26-9D81-D948FC140391 Q42687892-CB2C4B3C-179C-4E24-AA29-87057701BDC0 Q47548020-78A1696B-9269-47D2-8A8A-9069E13996EB Q50916986-DCB582D0-3449-44AE-9690-3015BE487E1F Q51046274-D5765FFD-D8F5-4E8B-9C7A-225E5BCE9992 Q53085284-063060F8-A56B-4C1A-85E6-FBC267004D74 Q54117313-5BBBD5DA-1DB9-43E7-BD18-6D097F5723DA Q54343325-4F379490-FB99-4363-AECE-A4331AC2FD65 Q54940651-748CD6A8-7CF4-4FB8-BCFB-987F3F6C0F04 Q55396331-E30EA76F-3F9B-4FD7-8D9A-15CBA0227E45

P2860

A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry

http://www.wikidata.org/entity/Q34405695

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@ast

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@en

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@nl

type

label

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@ast

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@en

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@nl

prefLabel

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@ast

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@en

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@nl

P1433

Q34405695-BD697431-6EAE-4D90-9B37-33D2A6AFD48C

P1476

Q34405695-0B3A4BF6-1FF5-4E3C-B0FA-D91BFB7E94BD

P2093

Q34405695-0317C341-C430-4A84-8FC4-A603D83985B9

Q34405695-4EA2E3B6-6FCF-4EA5-9AD0-38C0F952E9A7

Q34405695-664AC9EB-1B98-40AA-BF63-346C728CB36D

Q34405695-7277C10C-85D0-4A44-8900-43D5525DD735

Q34405695-7F9D4E8D-7437-47D6-A9ED-CA7441515D78

Q34405695-89F352B2-1053-4997-978B-E090D45343E8

Q34405695-8D89F727-A892-44D0-ADC0-EE47D626A5C6

Q34405695-ABB352B8-3CE7-4597-82F7-4E3476F76EBD

Q34405695-D7B8ED45-D528-4D85-8A1C-5286DC083896

Q34405695-F5366191-DB47-4815-9A16-8F83D22EA5FA

P2860

Q34405695-105334F7-E9BF-48BC-9A6E-A8F33EE3D9EE

Q34405695-1F518848-B25C-44C4-92DB-7AACD419E4B4

Q34405695-20107BC3-8411-4A6D-8E1D-2D9608C474A3

Q34405695-2B8626D0-46D4-4370-B000-A12B93EDA507

Q34405695-2BBC4E1C-4F60-4038-A7A4-895DF97A2B6C

Q34405695-2DA94210-B5E9-4EBC-B92B-2D9650D786D0

Q34405695-2EA0D5CB-70B2-48E4-A54B-36C72F53A78D

Q34405695-30BFC3FF-F98D-464B-AD47-4AD21A704503

Q34405695-38109DE5-B6CE-4EAE-B861-D3DCC058237D

Q34405695-39A171DC-FD56-41B9-873A-18137E5D9098

P304

Q34405695-00B69170-419D-4040-88B9-849F1020F18C

P31

Q34405695-661FC7C0-38CD-420E-862C-5ED3DBC0D096

P356

Q34405695-E2297010-4BB2-4E24-9C3B-BEDFE6F604A9

P407

Q34405695-6923489C-7D38-4DDC-943F-15E5FED9A172

P433

Q34405695-D4AFF166-F8CE-4715-9066-4C443C17145F

P478

Q34405695-DEFCC7E2-D437-4F4D-9BE3-8B480F909BA7

P577

Q34405695-FA61DFF3-9AEE-4E56-A1A3-15F4F5AC744E

P5875

Q34405695-8E374902-4D42-4499-8BBB-511464AB2042

P698

Q34405695-06B4C824-A71C-46E2-8179-899F56F6F717

P921

Q34405695-9AD5F302-4D7B-4A81-9989-A2AF8AE74C03

P932

Q34405695-D3F6C670-663C-487A-B8A8-03415A19CAA7

P356

JOURNAL.PONE.0043842

P1433

P1476

A comparison of EGFR mutation ...... e PCR and immunohistochemistry

@en

P2093

Ana Suárez-Gauthier

http://www.w3.org/2001/XMLSchema#string

Belén Rubio-Viqueira

http://www.w3.org/2001/XMLSchema#string

Bárbara Angulo

http://www.w3.org/2001/XMLSchema#string

Carlos Plaza

http://www.w3.org/2001/XMLSchema#string

Elisa Izquierdo

http://www.w3.org/2001/XMLSchema#string

Esther Conde

http://www.w3.org/2001/XMLSchema#string

Fernando López-Ríos

http://www.w3.org/2001/XMLSchema#string

Luis Paz-Ares

http://www.w3.org/2001/XMLSchema#string

Manuel Hidalgo

http://www.w3.org/2001/XMLSchema#string

Pilar Redondo

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Epidermal growth factor receptor mutations in lung cancer

Screening for epidermal growth factor receptor mutations in lung cancer

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis.

The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.

P304

e43842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0043842

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230805337

http://www.w3.org/2001/XMLSchema#string

P698

22952784

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

3428292

http://www.w3.org/2001/XMLSchema#string